Physician profile
Haley Simons Becker
NPI 1295394955
$599.65
in general payments reported to CMS, 2019-2025
11 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Registered Nurse provider received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.04 · 2022: $171 · 2023: $49.63 · 2024: $111 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $217.33 | 2021-2024 | Prolia, Evenity |
| Biogen, INC. | $77.11 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $73.22 | 2025 | Ova1 |
| Myovant Sciences INC. | $45.62 | 2021-2022 | |
| Agile Therapeutics, INC. | $40.92 | 2022 | |
| Therapeuticsmd, INC. | $36.31 | 2022 | |
| Currax Pharmaceuticals LLC | $32.70 | 2025 | Contrave |
| Sumitomo Pharma America, INC. | $31.94 | 2024 | Myfembree |
| Abbvie INC. | $17.52 | 2022 | |
| Exact Sciences Corporation | $13.59 | 2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $13.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.